{"product_id":"ipa-cjc-ipamorelin-cjc-1257-10-10mg","title":"IPA + CJC Blend (Ipamorelin + CJC-1295) 10\/10mg","description":"\u003ch2 data-section-id=\"rmw5tv\" data-start=\"0\" data-end=\"14\"\u003eDescription\u003c\/h2\u003e\n\u003cp\u003eQuickPen Pro IPA+CJC Blend (Ipamorelin 10mg + CJC-1295 10mg)\u003c\/p\u003e\n\u003cp data-start=\"16\" data-end=\"301\"\u003eThis advanced growth hormone support peptide formulation combines Ipamorelin 10mg and CJC-1295 10mg into a unified endocrine and recovery optimization blend designed for research involving growth hormone signaling, recovery physiology, metabolic regulation, and healthy aging pathways.\u003c\/p\u003e\n\u003cp data-start=\"303\" data-end=\"718\"\u003eIpamorelin is a selective growth hormone secretagogue studied for its ability to stimulate pulsatile growth hormone release through ghrelin receptor activation while maintaining a highly selective signaling profile. CJC-1295 is a long-acting growth hormone releasing hormone (GHRH) analog investigated for prolonged stimulation of endogenous growth hormone and IGF-1 pathways through pituitary signaling modulation.\u003c\/p\u003e\n\u003cp data-start=\"720\" data-end=\"1175\"\u003eTogether, this blend is positioned within experimental frameworks examining synergistic support of physiological growth hormone pulsatility, recovery dynamics, tissue regeneration signaling, sleep-associated anabolic activity, and metabolic resilience. Rather than functioning as direct exogenous hormone replacement, the peptide complex is investigated for its role in supporting endogenous endocrine rhythm optimization and adaptive recovery mechanisms.\u003c\/p\u003e\n\u003cp data-start=\"1177\" data-end=\"1397\"\u003eResearch domains include recovery physiology, lean tissue signaling, metabolic efficiency, sleep-related growth hormone dynamics, exercise recovery, body composition research, and longevity-associated endocrine pathways.\u003c\/p\u003e\n\u003cp data-start=\"1399\" data-end=\"1841\"\u003eOur formulation is provided in a stabilized pre-mixed injection pen for SubQ administration. Subcutaneous delivery supports consistent systemic exposure and reliable peptide absorption in research protocols. Each unit is freshly prepared to preserve peptide integrity and ensure standardized dosing. This format eliminates multi-step reconstitution and simplifies laboratory handling. The product is formulated strictly for research use only.\u003c\/p\u003e\n\u003cdiv class=\"elementor-element elementor-element-70108bd elementor-widget elementor-widget-heading\" data-id=\"70108bd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\"\u003e\n\u003ch3 class=\"elementor-heading-title elementor-size-default\"\u003ePen Dosage Chart\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"elementor-element elementor-element-a2c1f5a color-scheme-inherit text-left elementor-widget elementor-widget-text-editor\" data-id=\"a2c1f5a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\"\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"10\"\u003e\n\u003ccolgroup\u003e \u003ccol width=\"50%\"\u003e \u003ccol width=\"50%\"\u003e \u003c\/colgroup\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eQuickPen Pro IPA+CJC Blend (Ipamorelin 10mg + CJC-1295 10mg) \u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVolume\u003c\/td\u003e\n\u003ctd\u003e3.0 mL\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003emg\/mL\u003c\/td\u003e\n\u003ctd\u003e3.33 mg\/mL of each peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClick-to-Dose\u003c\/td\u003e\n\u003ctd\u003e1 click = 0.033 mg of each peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExample(s)\u003c\/td\u003e\n\u003ctd\u003e30 clicks(10 of Pen Scale) = 1 mg of each peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003chr data-start=\"1843\" data-end=\"1846\"\u003e\n\u003ch2 data-section-id=\"1v31agu\" data-start=\"1848\" data-end=\"1866\"\u003eClinical Status\u003c\/h2\u003e\n\u003cp data-start=\"1868\" data-end=\"1921\"\u003eHuman RCT ▣ | Observational ✔ | Animal ✔ | In vitro ✔\u003c\/p\u003e\n\u003cp data-start=\"1923\" data-end=\"2071\"\u003ePrimarily studied in endocrine, metabolic, and recovery-focused research settings, with expanding investigation in growth hormone modulation models.\u003c\/p\u003e\n\u003chr data-start=\"2073\" data-end=\"2076\"\u003e\n\u003ch2 data-section-id=\"uz8gfd\" data-start=\"2078\" data-end=\"2100\"\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp data-start=\"2102\" data-end=\"2742\"\u003eThis peptide blend is studied for its combined influence on endogenous growth hormone secretion and downstream anabolic signaling pathways. Ipamorelin selectively activates ghrelin (GHS-R1a) receptors involved in pulsatile growth hormone release while minimizing activity on cortisol and prolactin pathways in experimental systems. CJC-1295 functions as a growth hormone releasing hormone analog that prolongs pituitary stimulation and supports sustained growth hormone signaling. Together, these mechanisms may enhance physiological GH pulse amplitude, IGF-1 activity, recovery signaling, and metabolic regulation in research environments.\u003c\/p\u003e\n\u003chr data-start=\"2744\" data-end=\"2747\"\u003e\n\u003ch1 data-section-id=\"b8y6te\" data-start=\"2749\" data-end=\"2759\"\u003eBenefits\u003c\/h1\u003e\n\u003ch3 data-section-id=\"1il0918\" data-start=\"2761\" data-end=\"2811\"\u003eSupports Endogenous Growth Hormone Pulsatility\u003c\/h3\u003e\n\u003cp data-start=\"2813\" data-end=\"3118\"\u003eIpamorelin and CJC-1295 are extensively studied for their complementary activity in supporting physiological growth hormone release patterns. Experimental models examine how synchronized GHRH and ghrelin receptor signaling may optimize pulsatile GH dynamics and downstream anabolic communication pathways.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1qdzw54\" data-start=\"3120\" data-end=\"3177\"\u003eExamined In Recovery And Regenerative Research Models\u003c\/h3\u003e\n\u003cp data-start=\"3179\" data-end=\"3460\"\u003eGrowth hormone signaling plays a central role in tissue recovery, cellular repair, and adaptive regeneration. Research involving this blend explores recovery-supportive pathways associated with muscle repair, connective tissue resilience, and post-stress physiological restoration.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1nvibgv\" data-start=\"3462\" data-end=\"3512\"\u003eSupports IGF-1 And Anabolic Signaling Pathways\u003c\/h3\u003e\n\u003cp data-start=\"3514\" data-end=\"3827\"\u003eCJC-1295-mediated stimulation of endogenous growth hormone release contributes to downstream IGF-1 signaling activity. Combined with Ipamorelin-associated GH pulse amplification, the blend is studied within anabolic signaling frameworks involving tissue maintenance, recovery physiology, and metabolic adaptation.\u003c\/p\u003e\n\u003ch3 data-section-id=\"1k9hwq5\" data-start=\"3829\" data-end=\"3876\"\u003eSupports Sleep-Associated Recovery Dynamics\u003c\/h3\u003e\n\u003cp data-start=\"3878\" data-end=\"4207\"\u003eGrowth hormone release is closely linked to deep sleep physiology and nocturnal recovery processes. Experimental systems involving Ipamorelin examine interactions between GH pulsatility and sleep-related restorative signaling pathways. These mechanisms position the blend within integrated recovery and sleep-regulation research.\u003c\/p\u003e\n\u003ch3 data-section-id=\"zjzc07\" data-start=\"4209\" data-end=\"4266\"\u003eExamined In Lean Tissue And Body Composition Research\u003c\/h3\u003e\n\u003cp data-start=\"4268\" data-end=\"4571\"\u003eResearch involving growth hormone secretagogues frequently explores pathways associated with lean tissue maintenance, metabolic efficiency, and nutrient partitioning. Experimental models evaluate how optimization of endogenous GH signaling may influence body composition dynamics and energy utilization.\u003c\/p\u003e\n\u003ch3 data-section-id=\"z5pcfr\" data-start=\"4573\" data-end=\"4625\"\u003eSupports Metabolic Regulation And Energy Balance\u003c\/h3\u003e\n\u003cp data-start=\"4627\" data-end=\"4935\"\u003eGrowth hormone and IGF-1 signaling influence lipid metabolism, glucose utilization, and energy regulation pathways. Studies involving Ipamorelin and CJC-1295 examine how peptide-mediated endocrine modulation may support metabolic flexibility and adaptive energy balance under physiological stress conditions.\u003c\/p\u003e\n\u003ch3 data-section-id=\"14pc75e\" data-start=\"4937\" data-end=\"5013\"\u003eDistinct Regulatory Profile Compared To Exogenous Hormone Administration\u003c\/h3\u003e\n\u003cp data-start=\"5015\" data-end=\"5344\"\u003eUnlike direct growth hormone replacement strategies, this peptide blend is investigated for stimulation of endogenous hormonal rhythms through physiological signaling pathways. Research focuses on supporting natural endocrine communication and pulsatile hormone release dynamics rather than continuous exogenous hormone exposure.\u003c\/p\u003e\n\u003ch3 data-section-id=\"bjf6mk\" data-start=\"5346\" data-end=\"5412\"\u003eSupports Exercise Recovery And Performance Physiology Research\u003c\/h3\u003e\n\u003cp data-start=\"5414\" data-end=\"5692\"\u003eExperimental models involving physical stress and intensive training examine how enhanced growth hormone signaling may influence recovery capacity, tissue adaptation, and muscular resilience. This blend is studied within broader performance and recovery optimization frameworks.\u003c\/p\u003e\n\u003ch3 data-section-id=\"n9wyh\" data-start=\"5694\" data-end=\"5756\"\u003eIntegrated Endocrine–Recovery–Longevity Research Framework\u003c\/h3\u003e\n\u003cp data-start=\"5758\" data-end=\"6152\" data-is-last-node=\"\" data-is-only-node=\"\"\u003eGrowth hormone signaling, recovery physiology, metabolic regulation, and healthy aging are deeply interconnected biological systems. The Ipamorelin + CJC-1295 blend is studied within integrated research models examining how optimization of endogenous anabolic signaling pathways may influence long-term recovery efficiency, tissue resilience, metabolic stability, and physiological performance.\u003c\/p\u003e","brand":"Quickpen Pro Peptides","offers":[{"title":"Default Title","offer_id":57346297692537,"sku":null,"price":159.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0999\/0776\/4601\/files\/ipa-cjc-blend-ipamorelin-cjc-1295-1010mg-4729651.png?v=1780122490","url":"https:\/\/www.quickpen.pro\/products\/ipa-cjc-ipamorelin-cjc-1257-10-10mg","provider":"Quickpen Pro Peptides","version":"1.0","type":"link"}